The treatment of the congenital nasolacrimal duct obstruction
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

National Natural Science Foundation of China(No.81803258)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Congenital nasolacrimal duct obstruction(CNLDO)has an incidence rate of 5.7% and there are many clinical treatments for the disease. But these treatments have been taken very randomly. Therefore, it is still a controversial topic on how to choose the best treatment. This paper will discuss the treatments of CNLDO so as to know the characteristics of each treatment for better clinical services.

    Reference
    Related
    Cited by
Get Citation

Shu Han, Hui Zhu, Xiao-Jun Zhang. The treatment of the congenital nasolacrimal duct obstruction. Guoji Yanke Zazhi( Int Eye Sci) 2020;20(8):1359-1362

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:October 14,2019
  • Revised:May 26,2020
  • Adopted:
  • Online: July 22,2020
  • Published: